Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MidregiOnal Proatrial Natriuretic Peptide to Guide SEcondary Stroke Prevention: The MOSES-study. An International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial

NCT03961334 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.

NCT NCT03961334
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03961334 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MidregiOnal Proatrial Natriuretic Peptide to Guide SEcondary Stroke Prevention: The MOSES-study. An International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial
Lead sponsor
University of Zurich
Phase
Phase 3
Overall status
Unknown status
Start date
December 5, 2019
Completion date
January 31, 2026
Enrollment
620 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

stroke, ischemic